New functionality and detector system was successfully exhibited at AAPM in
Philadelphia.
Philadelphia.
C-RAD AB with its three fully owned subsidiaries are all active in the field of
radiation therapy. The company attended and exhibited at the annual physicist
meeting AAPM in Philadelphia, USA, 18-21 July. The GEMini and Sentinel systems
were presented in the C-RAD booth. The Sentinel system was also exhibited in the
Elekta booth with the robotic couch Hexapod Evo.
The annual physicist meeting AAPM in the US is one of the major events in
radiation therapy. The main focus for C-RAD this year was to introduce new
software functionality for respiratory gating and to present the GEMini ED
system. Both systems are FDA- pending. The meeting was a success. Compared to
last year´s meeting number of leads doubled. Both the ROS representative and the
new C-RAD sales manager in the US were busy in demonstrating the unique features
of the Sentinel system. New orders for the Sentinel system were signed.
This important meeting is also offering an opportunity to meet partners and
representatives. Both technical and commercial discussions took place to
integrate the C-RAD systems with the systems of the main vendors in radiation
therapy.
Erik Hedlund, CEO, C-RAD AB:
”USA represents almost 50% of the world market in radiation therapy. Success on
this market has also a positive impact on sales in rest of the world. To
penetrate this market, investment in marketing and sales will be further
increased."
For further information:
Erik Hedlund, CEO C-RAD AB, Telephone: +46- 18 - 66 69 31, E-Mail:
erik.hedlund@c-rad.se
About C-RAD AB
C-RAD develops new and innovative solutions for the use in advanced radiation
therapy. The company group of C-RAD offers products and solutions for patient
positioning, tumor localization and radiation treatment systems. End users are
radiation therapy clinics worldwide. All product development is conducted in
three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD
Innovation AB. C-RAD Imaging AB is located in Östersund while the other
companies are located in Uppsala. Numbers of employees are currently 19 people.
The activities in C-RAD AB originate from research and development at the
Karolinska Institute in Solna. Sales of the company's first product, the C-RAD
Sentinel TM, started in 2007. Cooperation agreements have been signed with the
Swedish company Elekta and the Belgian company IBA. C-RAD is represented by
distributors specialized in radiation therapy on major markets. C-RAD AB is
since March 2010 listed at Nasdaq Omx First North Premier.